Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Colorcon
Johnson and Johnson
McKinsey
Express Scripts
McKesson
Medtronic

Last Updated: November 22, 2019

DrugPatentWatch Database Preview

Drug Sales Trends for MIRTAZAPINE

See Plans and Pricing

« Back to Dashboard

Payment Methods and Pharmacy Types for MIRTAZAPINE (2017)

Revenues by Pharmacy Type

Pharmacy Type Revenues
MAIL-ORDER $3,622,108
INSIDE ANOTHER STORE $22,377,674
[disabled in preview] $180,838,021
This preview shows a limited data set
Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Pharmacy Type Units
MAIL-ORDER 196,775
INSIDE ANOTHER STORE 613,941
[disabled in preview] 5,285,226
This preview shows a limited data set
Subscribe for full access, or try a Trial

Revenues by Payment Method

Payment Method Revenues
MEDICAID $59,315,033
MEDICARE $102,345,731
[disabled in preview] $51,349,968
This preview shows a limited data set
Subscribe for full access, or try a Trial
Drug Sales Revenue Trends for MIRTAZAPINE
Drug Units Sold Trends for MIRTAZAPINE

Annual Sales Revenues and Units Sold for MIRTAZAPINE

These sales figures are drawn from a US national survey of drug expenditures
Drug Name Revenues (USD) Units Year
MIRTAZAPINE   Start Trial   Start Trial 2017
MIRTAZAPINE   Start Trial   Start Trial 2016
MIRTAZAPINE   Start Trial   Start Trial 2015
MIRTAZAPINE   Start Trial   Start Trial 2014
MIRTAZAPINE   Start Trial   Start Trial 2013
MIRTAZAPINE   Start Trial   Start Trial 2012
MIRTAZAPINE   Start Trial   Start Trial 2011
>Drug Name >Revenues (USD) >Units >Year

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKesson
Baxter
Moodys
Johnson and Johnson
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.